Verve Therapeutics
VERV
#5018
Rank
$1.10 B
Marketcap
$13.19
Share price
3.13%
Change (1 day)
-10.09%
Change (1 year)

P/S ratio for Verve Therapeutics (VERV)

P/S ratio as of March 2024 (TTM): 93.8

According to Verve Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 93.8032. At the end of 2023 the company had a P/S ratio of 95.3.

P/S ratio history for Verve Therapeutics from 2021 to 2023

PS ratio at the end of each year

Year P/S ratio Change
202395.3-84.47%
2022614
2021N/A